SARAH YOON: Open Payments
NPI 1669808465 · NILES, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,103 in 88 payments from 22 companies in 2025. Trend: 2023 $1,154 · 2024 $1,947 · 2025 $2,103
Food & beverage: $2,103
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $439 |
| ABBVIE INC. | 20 | $382 |
| Otsuka America Pharmaceutical, Inc. | 8 | $294 |
| Lilly USA, LLC | 8 | $167 |
| Lundbeck LLC | 10 | $139 |
| PFIZER INC. | 4 | $105 |
| Amgen Inc. | 4 | $81 |
| Xeris Pharmaceuticals, Inc. | 3 | $72 |
| ViiV Healthcare Company | 3 | $65 |
| Sumitomo Pharma America, Inc. | 2 | $56 |
Products named: REXULTI, Wegovy, VRAYLAR, UBRELVY, Ozempic, MOUNJARO, PREVNAR 20, OTEZLA.
Industry payments across IL — which companies pay providers there.
